{"id":25345,"date":"2025-12-29T17:06:35","date_gmt":"2025-12-29T09:06:35","guid":{"rendered":"https:\/\/www.hkioc.com.hk\/?p=25345"},"modified":"2025-12-29T17:06:35","modified_gmt":"2025-12-29T09:06:35","slug":"%e5%85%bc%e9%a1%be%e7%96%97%e6%95%88%e5%92%8c%e8%80%90%e5%8f%97%e6%80%a7%ef%bc%8cfda%e6%9c%80%e6%96%b0%e6%89%b9%e5%87%86cosibelimab%e7%94%a8%e4%ba%8e%e6%b2%bb%e7%96%97%e4%b8%8d%e9%80%82%e5%90%88","status":"publish","type":"post","link":"https:\/\/www.hkioc.com.hk\/zh-hans\/%e5%85%bc%e9%a1%be%e7%96%97%e6%95%88%e5%92%8c%e8%80%90%e5%8f%97%e6%80%a7%ef%bc%8cfda%e6%9c%80%e6%96%b0%e6%89%b9%e5%87%86cosibelimab%e7%94%a8%e4%ba%8e%e6%b2%bb%e7%96%97%e4%b8%8d%e9%80%82%e5%90%88\/","title":{"rendered":"\u517c\u987e\u7597\u6548\u548c\u8010\u53d7\u6027\uff0cFDA\u6700\u65b0\u6279\u51c6Cosibelimab\u7528\u4e8e\u6cbb\u7597\u4e0d\u9002\u5408\u624b\u672f\u7b49\u76ae\u80a4\u9cde\u72b6\u7ec6\u80de\u764c\u6210\u5e74\u60a3\u8005\u66f4\u65b0\u6807\u7b7e"},"content":{"rendered":"\n<p>\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u8fd1\u65e5\u5df2\u6279\u51c6cosibelimab-ipdl\u66f4\u65b0\u6807\u7b7e\uff0c<strong>\u7528\u4e8e\u6cbb\u7597\u4e0d\u9002\u5408\u63a5\u53d7\u6839\u6cbb\u6027\u624b\u672f\u6216\u653e\u5c04\u6cbb\u7597\u7684\u8f6c\u79fb\u6027\u6216\u5c40\u90e8\u665a\u671f\u76ae\u80a4\u9cde\u72b6\u7ec6\u80de\u764c\uff08CSCC\uff09\u6210\u5e74\u60a3\u8005\u3002<\/strong>\u66f4\u65b0\u540e\u7684\u6807\u7b7e\u57fa\u4e8eCK-301-101 1\u671f\u8bd5\u9a8c\uff08NCT03212404\uff09\u7684\u6700\u65b0\u7ed3\u679c\u3002<\/p>\n\n\n\n<p>\u8be5\u8bd5\u9a8c\u4e2d\uff0c\u7814\u7a76\u4eba\u5458\u8bc4\u4f30\u4e86cosibelimab\u5bf9109\u4f8b\u76ae\u80a4\u9cde\u72b6\u7ec6\u80de\u764c(CSCC)\u60a3\u8005\u7684\u6cbb\u7597\u6548\u679c\uff0c\u5176\u4e2d\u5c40\u90e8\u665a\u671f\u60a3\u800531\u4f8b\uff0c\u8f6c\u79fb\u6027\u60a3\u800578\u4f8b\uff1b\u7ed3\u679c\u53d1\u8868\u4e8e\u300aJournal of the American Academy of Dermatology\u300b(JAD)\u3002<\/p>\n\n\n\n<p>\u5728\u4e2d\u56fd\uff0c<strong>\u76ae\u80a4\u9cde\u72b6\u7ec6\u80de\u764c\u662f\u6240\u6709\u76ae\u80a4\u764c\u4e2d\u53d1\u75c5\u7387\u6700\u9ad8\u7684<\/strong>\uff0c\u4f46\u5176\u5728\u6240\u6709\u764c\u75c7\u7c7b\u578b\u4e2d\u7684\u5177\u4f53\u5360\u6bd4\u6570\u636e\u8f83\u5c11\uff0c\u636e\u76f8\u5173\u7edf\u8ba1\u6307\u76ae\u80a4\u9cde\u72b6\u7ec6\u80de\u764c\u662f\u53d1\u75c5\u7387\u6392\u540d\u7b2c\u4e00\u7684\u76ae\u80a4\u764c\u3002\u5b83\u597d\u53d1\u4e8e\u4e2d\u8001\u5e74\u4eba\uff0c\u7537\u6027\u53d1\u75c5\u7387\u9ad8\u4e8e\u5973\u6027\u3002&nbsp;<\/p>\n\n\n\n<p>\u800c\u5728\u9999\u6e2f\uff0c<strong>\u9cde\u72b6\u7ec6\u80de\u7624\u60a3\u8005\u7ea6\u5360\u76ae\u80a4\u764c\u768430%<\/strong>\u3002\u5c3d\u7ba1\u76ae\u80a4\u764c\u5728\u9999\u6e2f\u7684\u53d1\u75c5\u7387\u8fdc\u8fdc\u4f4e\u4e8e\u897f\u65b9\uff08\u5982\u7f8e\u56fd\uff09\uff0c\u4e0d\u8fc7\u4ece2012\u5e74\u81f32022\u5e74\u768410\u5e74\u95f4\uff0c\u9999\u6e2f\u76ae\u80a4\u764c\u65b0\u75c7\u670912%\u7684\u663e\u7740\u589e\u957f\uff0c\u60a3\u8005\u591a\u4e3a50\u5c81\u4ee5\u4e0a\u4eba\u58eb\u3002\u8fd9\u4e9b\u665a\u671f\u60a3\u8005\u9762\u4e34\u6cbb\u7597\u7684\u9009\u62e9\u6709\u9650\uff0c\u5176\u533b\u7597\u9700\u6c42\u4ecd\u672a\u5f97\u5230\u5145\u5206\u6ee1\u8db3\u3002<\/p>\n\n\n\n<p>\u6b64\u6b21\u6807\u7b7e\u66f4\u65b0\u4e86\u665a\u671f\u76ae\u80a4\u9cde\u72b6\u7ec6\u80de\u764c\uff08CSCC\uff09\u6cbb\u7597\u591a\u6837\u6027\u7684\u91cd\u8981\u6027\uff0c\u201c\u5bf9\u4e8e\u90a3\u4e9b\u6b63\u5728\u4e0e\u8fd9\u79cd\u75be\u75c5\u4f5c\u6597\u4e89\u5e76\u6e34\u671b\u83b7\u5f97\u7597\u6548\u663e\u8457\u4e14\u8010\u53d7\u6027\u826f\u597d\u7684\u6cbb\u7597\u65b9\u6848\u7684\u60a3\u8005\u6765\u8bf4\uff0c\u80fd\u591f\u83b7\u5f97\u4e00\u79cd\u4f5c\u7528\u673a\u5236\u4e0e\u5176\u4ed6\u514d\u75ab\u68c0\u67e5\u70b9\u6291\u5236\u5242\u4e0d\u540c\u7684\u6cbb\u7597\u9009\u62e9\uff0c\u65e0\u7591\u5c06\u5927\u6709\u88e8\u76ca\u3002\u201d<\/p>\n\n\n\n<p><strong>\u4e34\u5e8a\u8bd5\u9a8c\u548c\u6570\u636e\uff1a<\/strong><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/yH5BAEAAAAALAAAAAABAAEAAAIBRAA7\" data-src=\"https:\/\/www.hkioc.com.hk\/wp-content\/uploads\/2025\/12\/9419bc56a1d4fcc2a2c1047a7c01dbbb-1024x287.jpg\" data-srcset=\"https:\/\/www.hkioc.com.hk\/wp-content\/uploads\/2025\/12\/9419bc56a1d4fcc2a2c1047a7c01dbbb-1024x287.jpg 1024w, https:\/\/www.hkioc.com.hk\/wp-content\/uploads\/2025\/12\/9419bc56a1d4fcc2a2c1047a7c01dbbb-300x84.jpg 300w, https:\/\/www.hkioc.com.hk\/wp-content\/uploads\/2025\/12\/9419bc56a1d4fcc2a2c1047a7c01dbbb-768x215.jpg 768w, https:\/\/www.hkioc.com.hk\/wp-content\/uploads\/2025\/12\/9419bc56a1d4fcc2a2c1047a7c01dbbb-1536x431.jpg 1536w, https:\/\/www.hkioc.com.hk\/wp-content\/uploads\/2025\/12\/9419bc56a1d4fcc2a2c1047a7c01dbbb.jpg 1754w\" decoding=\"async\" width=\"1024\" height=\"287\" alt=\"\" class=\"wp-image-25394 lazyload\" sizes=\"(max-width: 1024px) 100vw, 1024px\"><noscript><img decoding=\"async\" width=\"1024\" height=\"287\" src=\"https:\/\/www.hkioc.com.hk\/wp-content\/uploads\/2025\/12\/9419bc56a1d4fcc2a2c1047a7c01dbbb-1024x287.jpg\" alt=\"\" class=\"wp-image-25394\" srcset=\"https:\/\/www.hkioc.com.hk\/wp-content\/uploads\/2025\/12\/9419bc56a1d4fcc2a2c1047a7c01dbbb-1024x287.jpg 1024w, https:\/\/www.hkioc.com.hk\/wp-content\/uploads\/2025\/12\/9419bc56a1d4fcc2a2c1047a7c01dbbb-300x84.jpg 300w, https:\/\/www.hkioc.com.hk\/wp-content\/uploads\/2025\/12\/9419bc56a1d4fcc2a2c1047a7c01dbbb-768x215.jpg 768w, https:\/\/www.hkioc.com.hk\/wp-content\/uploads\/2025\/12\/9419bc56a1d4fcc2a2c1047a7c01dbbb-1536x431.jpg 1536w, https:\/\/www.hkioc.com.hk\/wp-content\/uploads\/2025\/12\/9419bc56a1d4fcc2a2c1047a7c01dbbb.jpg 1754w\" sizes=\"(max-width: 1024px) 100vw, 1024px\"><\/noscript><\/figure><\/div>\n\n\n<p>\u6570\u636e\u663e\u793a\uff0c\u8f6c\u79fb\u6027\u75be\u75c5\u7ec4\u7684\u4e2d\u4f4d\u7f13\u89e3\u6301\u7eed\u65f6\u95f4\uff08DOR\uff09\u5c1a\u672a\u8fbe\u5230\uff0c\u5c40\u90e8\u665a\u671f\u75be\u75c5\u7ec4\u7684\u4e2d\u4f4d\u7f13\u89e3\u6301\u7eed\u65f6\u95f4\u4e5f\u672a\u8fbe\u5230\u3002\u6839\u636eKaplan-Meier\u5206\u6790\uff0c\u5404\u7ec4\u7684\u4f30\u8ba1\u7f13\u89e3\u6982\u7387\u57286\u4e2a\u6708\u65f6\u5206\u522b\u4e3a89.5%\u548c100%\uff0c\u572812\u4e2a\u6708\u65f6\u5206\u522b\u4e3a75.4%\u548c88.2%\uff0c\u572824\u4e2a\u6708\u65f6\u5206\u522b\u4e3a72.1%\u548c80.2%\u3002<\/p>\n\n\n\n<p>\u603b\u4f53\u800c\u8a00\uff0c94.3%\u7684\u60a3\u8005\u66fe\u62a5\u544a\u7ecf\u5386\u4e0d\u540c\u7ea7\u522b\u7684\u6cbb\u7597\u671f\u95f4\u51fa\u73b0\u7684\u4e0d\u826f\u53cd\u5e94(TEAE)\uff0c\u5176\u4e2d45.3%\u7684\u60a3\u8005\u51fa\u73b0\u4e863\u7ea7\u6216\u66f4\u9ad8\u7ea7\u522b\u7684\u6bd2\u6027\u53cd\u5e94\u3002<strong>\u6700\u5e38\u89c1\u7684\u4efb\u4f55\u7ea7\u522b\u7684TEAE\u5305\u62ec\u75b2\u4e4f(22.9%)\u3001\u8d2b\u8840(20.3%)\u3001\u4fbf\u79d8(16.1%)\u3001\u8179\u6cfb(15.1%)\u548c\u7619\u75d2(13.5%)<\/strong>\u3002TEAE\u5bfc\u81f46.3%\u7684\u60a3\u8005\u505c\u6b62\u6cbb\u7597\uff0c3.1%\u7684\u60a3\u8005\u56e0TEAE\u6b7b\u4ea1\u3002<\/p>\n\n\n\n<p>\u201c\u5c3d\u7ba1\u665a\u671f\u76ae\u80a4\u9cde\u72b6\u7ec6\u80de\u764c\uff08CSCC\uff09\u7684\u6cbb\u7597\u53d6\u5f97\u4e86\u8fdb\u5c55\uff0c\u4f46\u5bf9\u4e8e\u7597\u6548\u6301\u4e45\u3001\u8010\u53d7\u6027\u826f\u597d\u7684\u7597\u6cd5\u4ecd\u5b58\u5728\u5de8\u5927\u7684\u672a\u6ee1\u8db3\u9700\u6c42\u3002\u8fd9\u5bf9\u4e8e\u60a3\u6709\u591a\u79cd\u5408\u5e76\u75c7\u7684\u8001\u9f84\u5316\u60a3\u8005\u7fa4\u4f53\u5c24\u4e3a\u91cd\u8981\uff0c\u201d\u8be5\u7814\u7a76\u7684\u4e3b\u8981\u4e13\u5bb6\u8868\u793a\uff0c\u5bf9\u4e8e\u8bb8\u591a65\u5c81\u4ee5\u4e0a\u3001\u60a3\u6709\u591a\u79cd\u5408\u5e76\u75c7\u7684\u665a\u671fCSCC\u60a3\u8005\u6765\u8bf4\uff0c<strong>Cosibelimab\u63d0\u4f9b\u4e86\u4e00\u79cd\u91cd\u8981\u7684\u5168\u65b0\u6cbb\u7597\u9009\u62e9\uff0c\u517c\u987e\u4e86\u7597\u6548\u548c\u8010\u53d7\u6027<\/strong>\u3002<\/p>\n\n\n\n<p>\u76ee\u524d\u7814\u7a76\u8005\u8fd8\u8bc4\u4f30\u4e86cosibelimab\u5728\u5176\u4ed6\u7c7b\u578b\u5b9e\u4f53\u7624\u60a3\u8005\u4e2d\u7684\u7597\u6548\uff0c\u5305\u62ec\u4f46\u4e0d\u9650\u4e8e\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u3001\u7ed3\u76f4\u80a0\u764c\u3001\u5b50\u5bab\u5185\u819c\u764c\u3001\u6076\u6027\u80f8\u819c\u6216\u8179\u819c\u95f4\u76ae\u7624\u3001III\u671f\u6216\u8f6c\u79fb\u6027\u9ed1\u8272\u7d20\u7624\u4ee5\u53ca\u80be\u7ec6\u80de\u764c\u3002<\/p>\n\n\n\n<p>\u9999\u6e2f\u7efc\u5408\u80bf\u7624\u4e2d\u5fc3\u4e00\u76f4\u5bc6\u5207\u5173\u6ce8\u56fd\u9645\u524d\u6cbf\u521b\u65b0\u7597\u6cd5\u7b49\u7684\u540e\u7eed\u7814\u7a76\u52a8\u6001\uff0c\u5305\u62ec\u66f4\u5927\u89c4\u6a21\u7684\u4e34\u5e8a\u8bd5\u9a8c\u6570\u636e\uff0c\u4e3a\u9002\u5408\u7684\u60a3\u8005\u63d0\u4f9b\u524d\u6cbf\u6cbb\u7597\u8bc4\u4f30\u3002<\/p>\n\n\n\n<p>FDA\u6700\u521d\u4e8e2024\u5e7412\u6708\u6279\u51c6Cosibelimab\u7528\u4e8e\u6cbb\u7597\u5c40\u90e8\u665a\u671f\u6216\u8f6c\u79fb\u6027CSCC\u60a3\u8005\u3002FDA\u4e8e2025\u5e7412\u6708\u6279\u51c6cosibelimab-ipdl\u7684\u6807\u7b7e\u66f4\u65b0\uff0c\u57fa\u4e8e\u957f\u671f\u6570\u636e\uff0c<strong>\u8fd9\u4e9b\u6570\u636e\u8868\u660e\u8be5\u836f\u7269\u53ef\u6539\u5584\u665a\u671f\u76ae\u80a4\u9cde\u72b6\u7ec6\u80de\u764c\uff08aCSCC\uff09\u7684\u4e34\u5e8a\u7597\u6548<\/strong>\u3002<\/p>\n\n\n\n<p>\u8d44\u6599\u6765\u6e90\uff1a<\/p>\n\n\n\n<p>1.<a href=\"https:\/\/www.cancernetwork.com\/view\/fda-approves-updated-cosibelimab-label-in-cutaneous-squamous-cell-carcinoma\" data-type=\"link\" data-id=\"https:\/\/www.cancernetwork.com\/view\/fda-approves-updated-cosibelimab-label-in-cutaneous-squamous-cell-carcinoma\">https:\/\/www.cancernetwork.com\/view\/fda-approves-updated-cosibelimab-label-in-cutaneous-squamous-cell-carcinoma<\/a><\/p>\n\n\n\n<p>2.<a href=\"https:\/\/www.prnewswire.com\/news-releases\/fda-approves-label-update-for-unloxcyt-cosibelimab-ipdl-based-on-longer-term-data-that-demonstrated-improved-clinical-outcomes-in-advanced-cutaneous-squamous-cell-carcinoma-acscc-302626366.html\" data-type=\"link\" data-id=\"https:\/\/www.prnewswire.com\/news-releases\/fda-approves-label-update-for-unloxcyt-cosibelimab-ipdl-based-on-longer-term-data-that-demonstrated-improved-clinical-outcomes-in-advanced-cutaneous-squamous-cell-carcinoma-acscc-302626366.html\">https:\/\/www.prnewswire.com\/news-releases\/fda-approves-label-update-for-unloxcyt-cosibelimab-ipdl-based-on-longer-term-data-that-demonstrated-improved-clinical-outcomes-in-advanced-cutaneous-squamous-cell-carcinoma-acscc-302626366.html<\/a><\/p>\n\n\n\n<p>3.<a href=\"https:\/\/www.cancer.gov.hk\/tc\/hong_kong_cancer\/common_cancers_in_hong_kong\/skin_cancer.html\" data-type=\"link\" data-id=\"https:\/\/www.cancer.gov.hk\/tc\/hong_kong_cancer\/common_cancers_in_hong_kong\/skin_cancer.html\">https:\/\/www.cancer.gov.hk\/tc\/hong_kong_cancer\/common_cancers_in_hong_kong\/skin_cancer.html<\/a><\/p>\n\n\n\n<p>\u8f6c\u8f7d\u8bf7\u8054\u7cfb\u6388\u6743\uff0c\u6216\u6ce8\u660e\u6765\u6e90\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u8fd1\u65e5\u5df2\u6279\u51c6cosibelimab-ipdl\u66f4\u65b0\u6807\u7b7e\uff0c\u7528\u4e8e\u6cbb\u7597\u4e0d\u9002\u5408\u63a5\u53d7\u6839\u6cbb\u6027\u624b<\/p>\n","protected":false},"author":14,"featured_media":25331,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1769,6624],"tags":[],"yst_prominent_words":[],"class_list":["post-25345","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-treatment-zh-hans","category--zh-hans"],"_links":{"self":[{"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/posts\/25345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/comments?post=25345"}],"version-history":[{"count":3,"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/posts\/25345\/revisions"}],"predecessor-version":[{"id":25397,"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/posts\/25345\/revisions\/25397"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/media\/25331"}],"wp:attachment":[{"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/media?parent=25345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/categories?post=25345"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/tags?post=25345"},{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/www.hkioc.com.hk\/zh-hans\/wp-json\/wp\/v2\/yst_prominent_words?post=25345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}